Hedelix (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

Hedelix is indicated for the symptomatic relief of cough and mucus accumulation in various upper respiratory conditions.

• Cough associated with the common cold.
• Cough due to acute viral respiratory tract infections.
• Mild bronchial irritation with productive sputum.
• Adjunctive support in chronic bronchitis with intermittent exacerbations.
• Symptomatic relief of throat irritation related to mucus buildup.
• Relief of cough associated with mild allergic rhinitis.
• Supportive care during recovery from sinusitis with post‑nasal drip.
• and may be used as part of a broader symptomatic management plan.

The safety profile of Hedelix reflects the typical experience with oral ivy leaf extracts; most users report mild, transient events, while serious reactions are uncommon. These events are generally self‑limiting and do not require medical intervention.

Common

• Mild gastrointestinal discomfort such as nausea or stomach upset.
• Transient headache.
• Slight dizziness.
• Mild skin irritation or rash at the oral mucosa.
• Loose stools or mild diarrhea.
• Temporary metallic taste in the mouth.
• Mild fatigue or feeling of weakness.

Serious

• Allergic reactions including urticaria or angioedema.
• Severe bronchospasm or worsening of asthma symptoms.
• Hepatic enzyme elevation (rare) requiring monitoring.
• Anaphylactic shock (extremely rare) requiring emergency care.

When considering Hedelix, certain precautionary measures should be observed to ensure safe use, especially in specific population groups and clinical situations.

• Do not use if you have a known hypersensitivity to ivy leaf or any component of the extract.
• Use caution in patients with asthma, as ivy may provoke bronchospasm in susceptible individuals.
• Pregnant or breastfeeding women should consult a healthcare professional before use due to limited safety data.
• Children under a certain age should only use the product under medical guidance.
• Avoid concurrent use with other expectorants or mucolytic agents without professional advice.
• Discontinue use and seek medical attention if signs of an allergic reaction develop.

Hedelix may interact with certain medicines; awareness of these potential interactions helps avoid reduced efficacy or increased risk of adverse effects.

Avoid

• Concurrent use with other oral expectorants or mucolytics without medical supervision.
• Combining with medications that may cause bronchospasm, such as beta‑blockers in asthmatic patients.

Use with caution

• Antihistamines or corticosteroids, as they may alter the expected expectorant effect.
• Herbal supplements containing similar mucolytic constituents, e.g., thyme or primrose.
• Drugs metabolized by hepatic enzymes that could be affected by ethanol content, such as certain benzodiazepines.
• Patients on anticoagulant therapy should monitor for any unexpected bleeding, although evidence is limited.